Onxeo S.A.’s $6.6 Million Agreement with Acrotech Biopharma LLC

Ambrogio Visconti

Goodwin Procter LLP advised Onxeo S.A. on its agreements with Acrotech Biopharma LLC Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), a clinical-stage biotechnology company specializing in…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now